NEW YORK Genosity said on Tuesday that it has partnered with Columbia University to investigate the genetic underpinnings of wild-type cardiac amyloidosis, a rare condition characterized by the accumulation of abnormal proteins in the heart.

Although there is a heritable form of cardiac amyloidosis called transthyretin-related (TTR) amyloidosis that is caused by mutations in the gene that encodes the protein transthyretin, some individuals develop the disease without such mutations.

Originally posted here:
Genosity, Columbia University Partner to Study Genetics of Rare Heart Condition - GenomeWeb